The North America Microcarriers Market should witness market growth of 10.6% CAGR during the forecast period (2022-2028).
Production of vaccines is by far the most common use of microcarrier-based culture in bioreactors. This involves creating modified viruses used as vaccines using a cell line used for "packing." Vero cells and, to a lesser extent, MRC-5 cells, which have essentially been replaced, are the cell types that are employed the most frequently.
It is also possible to produce recombinant proteins, such as antibodies, using Chinese hamster ovary (CHO) cells. In these circumstances, the virus or protein product is secreted into the medium by the cells; the cells themselves are not retrieved. Microcarriers are seeing a rising demand in cell therapy, which has overtaken vaccine production as the second-largest market sector.
Currently, the bulk of cell therapies use non-adherent hematopoietic lineage cells that don't need a support substrate. However, as adherent MSC and iPSC-based therapies gain therapeutic potential, there will be a greater need for biomanufacturing capacity that can produce these adherent cell types at higher volumes.
The United States is the worldwide leader in biopharmaceutical research and development and has the biggest market for biopharmaceuticals, making up a large portion of The United States has one of the best environments in the world for developing and selling pharmaceuticals. There aren't many market barriers. Its strengths include a patent and data protection system that encourages innovation, a science-based regulatory system that is thought to be the most strict in the world, the world's largest scientific research base made possible by academic institutions as well as decades of government funding for research, and strong capital markets.
The US market dominated the North America Microcarriers Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $651 million by 2028. The Canada market is poised to grow at a CAGR of 13.1% during (2022-2028). Additionally, The Mexico market should witness a CAGR of 12.1% during (2022-2028).
Based on Consumables, the market is segmented into Microcarrier Beads and Media & Reagents. Based on Microcarrier Beads Type, the market is segmented into, Collagen Coated Beads, Cationic Beads, Protein Coated Beads, Untreated Beads and Others. Based on End-user, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations and Academic & Research Institutes. Based on Application, the market is segmented into Biopharmaceutical Production and Regenerative Medicine. Based on Biopharmaceutical Production Type, the market is segmented into Vaccine Production and Therapeutic Production. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Merck Group, Sartorius Stedim Biotech S.A. (Sartorius AG), Corning Incorporated, Bio-Rad Laboratories, Inc., Danaher Corporation, Eppendorf SE, HiMedia Laboratories Pvt. Ltd., and denovoMATRIX GmbH.
Production of vaccines is by far the most common use of microcarrier-based culture in bioreactors. This involves creating modified viruses used as vaccines using a cell line used for "packing." Vero cells and, to a lesser extent, MRC-5 cells, which have essentially been replaced, are the cell types that are employed the most frequently.
It is also possible to produce recombinant proteins, such as antibodies, using Chinese hamster ovary (CHO) cells. In these circumstances, the virus or protein product is secreted into the medium by the cells; the cells themselves are not retrieved. Microcarriers are seeing a rising demand in cell therapy, which has overtaken vaccine production as the second-largest market sector.
Currently, the bulk of cell therapies use non-adherent hematopoietic lineage cells that don't need a support substrate. However, as adherent MSC and iPSC-based therapies gain therapeutic potential, there will be a greater need for biomanufacturing capacity that can produce these adherent cell types at higher volumes.
The United States is the worldwide leader in biopharmaceutical research and development and has the biggest market for biopharmaceuticals, making up a large portion of The United States has one of the best environments in the world for developing and selling pharmaceuticals. There aren't many market barriers. Its strengths include a patent and data protection system that encourages innovation, a science-based regulatory system that is thought to be the most strict in the world, the world's largest scientific research base made possible by academic institutions as well as decades of government funding for research, and strong capital markets.
The US market dominated the North America Microcarriers Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $651 million by 2028. The Canada market is poised to grow at a CAGR of 13.1% during (2022-2028). Additionally, The Mexico market should witness a CAGR of 12.1% during (2022-2028).
Based on Consumables, the market is segmented into Microcarrier Beads and Media & Reagents. Based on Microcarrier Beads Type, the market is segmented into, Collagen Coated Beads, Cationic Beads, Protein Coated Beads, Untreated Beads and Others. Based on End-user, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations and Academic & Research Institutes. Based on Application, the market is segmented into Biopharmaceutical Production and Regenerative Medicine. Based on Biopharmaceutical Production Type, the market is segmented into Vaccine Production and Therapeutic Production. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Merck Group, Sartorius Stedim Biotech S.A. (Sartorius AG), Corning Incorporated, Bio-Rad Laboratories, Inc., Danaher Corporation, Eppendorf SE, HiMedia Laboratories Pvt. Ltd., and denovoMATRIX GmbH.
Scope of the Study
By Consumables
- Microcarrier Beads
- Collagen Coated Beads
- Cationic Beads
- Protein Coated Beads
- Untreated Beads
- Others
- Media & Reagents
By End-user
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations & Contract Manufacturing Organizations
- Academic & Research Institutes
By Application
- Biopharmaceutical Production
- Vaccine Production
- Therapeutic Production
- Regenerative Medicine
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Thermo Fisher Scientific, Inc.
- Merck Group
- Sartorius Stedim Biotech S.A. (Sartorius AG)
- Corning Incorporated
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Eppendorf SE
- HiMedia Laboratories Pvt. Ltd.
- denovoMATRIX GmbH
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. North America Microcarriers Market by Consumables
Chapter 4. North America Microcarriers Market by End-user
Chapter 5. North America Microcarriers Market by Application
Chapter 6. North America Microcarriers Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Thermo Fisher Scientific, Inc.
- Merck Group
- Sartorius Stedim Biotech S.A. (Sartorius AG)
- Corning Incorporated
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Eppendorf SE
- HiMedia Laboratories Pvt. Ltd.
- denovoMATRIX GmbH
Methodology
LOADING...
